4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
- Post author:admin
- Post published:April 3, 2025
- Post category:uncategorized
- Post comments:0 Comments